Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
暂无分享,去创建一个
Tim Hui-Ming Huang | Huidong Shi | Pearlly S Yan | Farahnaz Rahmatpanah | Huidong Shi | T. Hsiau | T. Huang | P. Yan | F. Rahmatpanah | Joseph C Liu | Yu-Wei Leu | Andrew H-A Hsiau | Joseph C. Liu | Timothy H-C Hsiau | Yu‐Wei Leu
[1] J. Minna,et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. , 2001, Journal of the National Cancer Institute.
[2] P. Marks,et al. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Laird,et al. COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.
[4] J. Kwong,et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. , 2001, Cancer research.
[5] A. Bird,et al. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. , 1994, Genes & development.
[6] J. Herman,et al. p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. , 1999, Blood.
[7] Huidong Shi,et al. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. , 2002, Genome research.
[8] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[9] M. Caligiuri,et al. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.
[10] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[11] A. Bird. CpG-rich islands and the function of DNA methylation , 1986, Nature.
[12] U. Lehmann,et al. Quantitative assessment of promoter hypermethylation during breast cancer development. , 2002, The American journal of pathology.
[13] M. Matsuoka,et al. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. , 2000, Cancer research.
[14] T. Huang,et al. Methylation profiling of CpG islands in human breast cancer cells. , 1999, Human molecular genetics.
[15] G. Yang,et al. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. , 2001, Cancer research.
[16] J. Herman,et al. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. , 2000, Cancer research.
[17] S. Clark,et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. , 1997, Cancer research.
[18] L. E. McDonald,et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Clark,et al. A Distinct Sequence (ATAAA) n Separates Methylated and Unmethylated Domains at the 5′-End of theGSTP1 CpG Island*210 , 2000, The Journal of Biological Chemistry.
[20] J. Issa,et al. Aging, DNA methylation and cancer. , 1999, Critical reviews in oncology/hematology.
[21] P. Vertino,et al. Effects of methylation on expression of TMS1/ASC in human breast cancer cells , 2003, Oncogene.
[22] C Eng,et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. , 2001, Human molecular genetics.
[23] Z. Siegfried,et al. Spl elements protect a CpG island from de novo methylation , 1994, Nature.
[24] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Groshen,et al. Progressive increases in de novo methylation of CpG islands in bladder cancer. , 2000, Cancer research.
[26] J. Minna,et al. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells , 2002, Oncogene.
[27] S. Clark,et al. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. , 1997, Nucleic acids research.
[28] J. Minna,et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours , 2001, Oncogene.
[29] A. Bird. DNA methylation patterns and epigenetic memory. , 2002, Genes & development.
[30] J. Herman,et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. , 2002, Cancer research.
[31] Stephen B. Baylin,et al. Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation* , 1997, The Journal of Biological Chemistry.
[32] G. Pfeifer,et al. Frequent hypermethylation of the RASSF1A gene in prostate cancer , 2002, Oncogene.
[33] Thomas D. Otto,et al. Tumour class prediction and discovery by microarray-based DNA methylation analysis , 2002 .
[34] E. Maher,et al. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients , 2003, Oncogene.